RPS6KB1 and plasma cell myeloma: Also, with the evidence that loss of mTOR resulted in an activation of ERK [57], the combination of decursin and doxorubicin upregulated the phosphorylation of ERK in the three multiple myeloma cells, indicating that ERK activation is associated with inhibition of mTOR/S6K1 signaling.